Publication | Closed Access
Cancer Molecular Screening and Therapeutics (MoST): a framework for multiple, parallel signal‐seeking studies of targeted therapies for rare and neglected cancers
55
Citations
18
References
2018
Year
Australia New Zealand Clinical Trials Registry: ACTRN12616000908437 (8 July 2016).
| Year | Citations | |
|---|---|---|
Page 1
Page 1